Articles From: Western Refining to Participate in the Tudor Pickering Holt & Company Energy Conference to Merck Announces First Presentation of Data on the Investigational Use of KEYTRUDA® (pembrolizumab) in Patients with Advanced Gastric Cancer at ESMO 2014


EL PASO, Texas, June 17, 2014 (GLOBE NEWSWIRE) -- Western Refining, Inc. (NYSE:WNR) announced today that Company management will participate in the Tudor Pickering Holt & Company Energy Conference, in Houston, Texas, on Wednesday, June 18, 2014.
Sign-up for Western Refining to Participate in the Tudor Pickering Holt & Company Energy Conference investment picks
NEW YORK, June 16, 2014 (GLOBE NEWSWIRE) -- The NASDAQ OMX Group, Inc. (Nasdaq:NDAQ) today announced the results of the quarterly re-ranking of the NASDAQ Golden Dragon China Index (Nasdaq:HXC), which will become effective prior to market open on Monday, June 23, 2014.
Sign-up for Quarterly Changes to the NASDAQ Golden Dragon China Index investment picks
NEW YORK, June 16, 2014 (GLOBE NEWSWIRE) -- The law firm Gardy & Notis, LLP has filed a securities fraud class action lawsuit on behalf of purchasers of Hertz Global Holdings, Inc. (NYSE:HTZ) securities stock during a class period of February 22, 2012 to June 6, 2014.
Sign-up for Securities Fraud Class Action Filed Against Hertz Global Holdings, Inc. - HTZ - by Gardy & Notis, LLP investment picks
2014/04/14
The bucket approach to retirement portfolio planning is a strategy for funding retirement cash-flow needs while also maintaining a diversified portfolio of stocks, bonds, and cash.
Sign-up for The Bucket Approach to Retirement Portfolio Construction investment picks
2013/04/19
Asset allocation is the biggest determinant of how your portfolio behaves.
Sign-up for Find the Right Stock/Bond Mix investment picks
2012/09/04
Understanding the differences and similarities between these two popular indexing strategies can affect your portfolio planning.
Sign-up for S&P 500 vs. Total Stock Market: Which Is Right for You? investment picks
2011/11/16
Strike the right balance between return potential and loss aversion.
Sign-up for The Right Investments for Short-Term Goals investment picks
2011/10/20
Make sure you're looking at more than just performance.
Sign-up for Keeping Tabs on Your Portfolio investment picks
2011/01/27
Investors have lost more than $160 billion in structured and complex income investments, says John Wasik.
Sign-up for Is a Structured Product Good for Retirement Income? investment picks
2010/12/28
Streamlining your retirement accounts? Think through the key variables first.
Sign-up for What You Need to Know About 401(k) Rollovers investment picks
2008/12/30
Tips for ensuring your assets flow to the right people.
Sign-up for How to Handle Beneficiary Designations investment picks
2007/12/13
Lock in your 2007 gains while keeping taxes low.
Sign-up for Harvest Gains in Your Portfolio investment picks
2014/9/28
By Wayne Ma AirAsia Bhd.
Sign-up for AirAsia: Establishes Unit For Aircraft Leasing Services investment picks
2014/9/28
By Robb M.
Sign-up for Australia's ANZ to Sell Stake in Saigon Securities investment picks
2014/9/28
New 'Facets of Abu Dhabi' livery reminiscent of desert landscape, inspired by culture of the United Arab Emirates Abu Dhabi-based airline one of the world's largest 787 customers EVERETT, Wash.
Sign-up for Boeing, Etihad Airways Unveil Livery of Airline's First 787-9 Dreamliner investment picks
ZUG, Switzerland, Sept.
Sign-up for Coca-Cola HBC AG Named Industry Leader in the 2014 Dow Jones Sustainability Index investment picks
SHANGHAI , Sept.
Sign-up for Ctrip To Purchase Certain Premises In Sky SOHO investment picks
Lead Compound, Quizartinib, Will Further Build Daiichi Sankyo Oncology Pipeline TOKYO and SAN DIEGO , Sept.
Sign-up for Daiichi Sankyo to Acquire Ambit Biosciences investment picks
Clovis Oncology (NASDAQ:CLVS) today announced preliminary Phase 2 results from the ARIEL2 ( A ssessment of R ucaparib I n Ovarian Canc e r Tria l ) study and updated results from the ongoing Phase 1/2 monotherapy study of rucaparib.
Sign-up for Data from Ongoing Phase 2 Studies of Rucaparib in Ovarian Cancer Demonstrate Safety and Clinical Activity, Validate Differentiated Strategy investment picks
By Russ Britt, MarketWatch The ever-bankable Denzel Washington helped Hollywood inch toward closing its year-to-year box-office deficit as his latest film, "The Equalizer," scored $35 million in U.S. theaters over the weekend and led all films in revenue.
Sign-up for Denzel Washington's new movie is a box-office 'equalizer' investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G022661-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/9/28/11G022661/20130207-eca_200-473944305185.jpg CALGARY, AB--(Marketwired - September 28, 2014) - Encana Corporation (TSX: ECA) (NYSE: ECA) will hold a conference call before the North American public markets open Monday, September 29, 2014.
Sign-up for Encana to Hold Conference Call Before North American Markets Open on Monday, September 29, 2014 investment picks
2014/9/28
By Leslie Scism Maurice R.
Sign-up for Hank Greenberg Challenges AIG Bailout investment picks
Ignyta, Inc. (Nasdaq: RXDX), an oncology precision medicine biotechnology company, announced today that interim results from the first-in-human ALKA-372-001 Phase I clinical trial of RXDX-101, the company’s proprietary oral tyrosine kinase inhibitor targeting solid tumor indications, were presented in a poster discussion session at the 2014 Congress of the European Society for Medical Oncology (ESMO) in Madrid, Spain.
Sign-up for Ignyta Announces Interim Data from RXDX-101 Phase I Clinical Trial at 2014 ESMO Congress investment picks
2014/9/28
By Wallace Witkowski, MarketWatch SAN FRANCISCO (MarketWatch) -- Investors will pick through several economic reports this week, but attention is likely to focus on jobs numbers due on Friday.
Sign-up for MARKET SNAPSHOT: Investors Likely To Focus On Jobs Data investment picks
Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the first presentation of data on the investigational use of KEYTRUDA ® (pembrolizumab) – the company’s anti-PD-1 therapy – in PD-L1 positive, advanced gastric cancer.
Sign-up for Merck Announces First Presentation of Data on the Investigational Use of KEYTRUDA® (pembrolizumab) in Patients with Advanced Gastric Cancer at ESMO 2014 investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Western Refining to Participate in the Tudor Pickering Holt & Company Energy Conference to Merck Announces First Presentation of Data on the Investigational Use of KEYTRUDA® (pembrolizumab) in Patients with Advanced Gastric Cancer at ESMO 2014
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices